Making Australia more medicinewise through digital health and data insights, health professional education and reliable health information for consumers

Changing from one antipsychotic drug to another can be challenging. Care is needed to avoid psychosis during the changeover.

New non-stimulant medicine for children and adolescents experiencing residual ADHD symptoms with stimulants

A primary care data and quality improvement program developed and managed by NPS MedicineWise with funding support from the Australian Government Department of Health. MedicineInsight supports quality improvement in general practice, post-market surveillance of medicines, Australian health policy and primary care research.

Enabling clinicians, consumers and healthcare stakeholders to start important conversations about tests, treatments and procedures where evidence shows they provide no benefit, or in some cases, lead to harm.